CorVel Corporation
NASDAQ:CRVLInsurance - Brokers
-$0.07 today
- Market cap
- $4.47B
- Beta
- 0.98
- P/E (TTM)
- 26.9
- EPS (TTM)
- $2.16
Volume 0.26M
Average 0.22M
CRVL Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
CorVel CorporationNASDAQ: CRVL
Accumulated OCI · Q2 FY2027 · quarter ended Sep 2026
Accumulated OCI remains negative
Q2 FY2027 Accumulated OCI was $0, compared with $0 a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q2 FY2027, unchanged from a year earlier.
- Accumulated OCI increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | — |
| FY2025 | 2025-03-31 | 0 | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | — |
| FY2022 | 2022-03-31 | 0 | — |
Accumulated OCI vs competitors
How CRVL compares with its peers on the latest reported figures
- CRVL's Sep 2026 Accumulated OCI of $0 is the highest of the 4 companies compared; the peer median is -$3.63M.
- Accumulated OCI amounts to 0.0% of total assets for CRVL, versus a peer median of 0.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $0 | — | — | 0.0% | |
CTEVClaritev Corporation | Mar 2026 | -$2.35M | +64.8% | — | 0.0% |
| Mar 2026 | -$3.63M | -109.7% | — | 0.2% | |
| Jul 2026 | -$69.05M | -34115.8% | — | 2.1% | |
| Peer median (excluding CRVL) | -$3.63M | -109.7% | — | 0.2% | |
Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 97.5M | 71.33M | 105.56M | 170.58M | 233.07M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 82.59M | 81.03M | 97.11M | 104.13M | 101.31M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 115.71M |
| Total Current Assets | 264.99M | 243.77M | 302.23M | 386.69M | 462.3M |
| Property, Plant & Equipment (Net) | 111.29M | 110.49M | 109.95M | 112.88M | 139.07M |
| Goodwill | 36.81M | 36.81M | 36.81M | 36.81M | 36.81M |
| Intangible Assets | 1.67M | 1.24M | 821K | 438K | 263K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 224K | 3.55M | 8.7M | 3.92M |
| Other Non-current Assets | 481K | 1.38M | 1.32M | 454K | 618K |
| Total Non-current Assets | 150.25M | 150.15M | 152.45M | 159.29M | 180.69M |
| Total Assets | 415.25M | 393.92M | 454.68M | 545.98M | 642.99M |
| Account Payables | 14.08M | 15.06M | 16.41M | 15.42M | 24.32M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 351K | 251K | 221K | 1.37M | 0 |
| Deferred Revenue | 95.58M | 107M | 118.1M | 132.28M | 147.94M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 171.37M | 167.89M | 184.5M | 204.04M | 228.07M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.69M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 31.48M | 23.86M | 22.53M | 19.95M | 20.69M |
| Total Liabilities | 202.85M | 191.75M | 207.03M | 223.99M | 248.76M |
| Common Stock | 3K | 3K | 3K | 5K | 5K |
| Retained Earnings | 665.3M | 731.67M | 807.92M | 903.09M | 1.01B |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 212.4M | 202.18M | 247.65M | 321.99M | 394.23M |
| Total Debt | 43.14M | 33.76M | 31.4M | 28.08M | 28.11M |
| Net Debt | (54.36M) | (37.57M) | (74.17M) | (142.51M) | (204.97M) |
CorVel Corporation
NASDAQ:CRVL
Intrinsic Alpha fair value
Locked
Current Price
$88.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.